NCAM1 and neoplasm: Alexander et al. observed that CD56+ γδ T cells are more resistant to FasL mediated apoptosis compared to CD56- γδ T cells suggesting that this relative apoptosis resistance could explain the enhanced anti-tumor activity of CD56+ γδ T cells.